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STUDY PROTOCOL Open Access
Study protocol of SWEPIS a Swedish
multicentre register based randomised
controlled trial to compare induction of
labour at 41 completed gestational weeks
versus expectant management and
induction at 42 completed gestational
weeks
Helen Elden1*, Henrik Hagberg2, Anna Wessberg1, Verena Sengpiel2, Andreas Herbst3, Maria Bullarbo2,
Christina Bergh4, Kristian Bolin5, Snezana Malbasic6, Sissel Saltvedt7, Olof Stephansson8,9, Anna-Karin Wikström10,
Lars Ladfors2 and Ulla-Britt Wennerholm2
Abstract
Background: Observational data shows that postterm pregnancy (≥42 gestational weeks, GW) and late term
pregnancy (≥41 GW), as compared to term pregnancy, is associated with an increased risk for adverse outcome for the
mother and infant. Standard care in many countries is induction of labour at 42 GW. There is insufficient scientific
support that induction of labour at 41 GW, as compared with expectant management and induction at 42 GW will
reduce perinatal mortality and morbidity without an increase in operative deliveries, negative delivery experiences or
higher costs. Large randomised studies are needed since important outcomes; such as perinatal mortality and hypoxic
ischaemic encephalopathy are rare events.
Methods/Design: A total of 10 038 healthy women ≥18 years old with a normal live singleton pregnancy in cephalic
presentation at 41 GW estimated with a first or second trimester ultrasound, who is able to understand oral and
written information will be randomised to labour induction at 41 GW (early induction) or expectant management and
induction at 42 GW (late induction). Women will be recruited at university clinics and county hospitals in Sweden
comprising more than 65 000 deliveries per year. Primary outcome will be a composite of stillbirth, neonatal mortality
and severe neonatal morbidity. Secondary outcomes will be other adverse neonatal and maternal outcomes, mode of
delivery, women’s experience, cost effectiveness and infant morbidity up to 3 months of age. Data on background
variables, obstetric and neonatal outcomes will be obtained from the Swedish Pregnancy Register and the Swedish
Neonatal Quality Register. Data on women’s experiences will be collected by questionnaires after randomisation and
3 months after delivery. Primary analysis will be intention to treat. The statistician will be blinded to group and
intervention.
(Continued on next page)
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Discussion: It is important to investigate if an intervention at 41 GW is superior to standard care in order to reduce
death and lifelong disability for the children. The pregnant population, >41 GW, constitutes 15–20 % of all pregnancies
and the results of the study will thus have a great impact. The use of registries for randomisation and collection of
outcome data represents a unique and new study design.
Trial registration: The study was registered in Current Controlled Trials, ISRCTN26113652 the 30th of March 2015 (DOI
10.1186/ISRCTN26113652).
Keywords: Prolonged pregnancy, Postterm, Labour, Induced, Expectant management, Perinatal outcome, Neonatal
outcome, Maternal outcome, Maternal preferences
Background
According to World Health Organisation (WHO), postterm
birth is defined as pregnancy duration of 294 days or longer,
i.e. gestational week (GW) 42 and 0 days (42+0) or more,
measured from the first day of the last menstrual period [1].
This definition is arbitrary. Many studies that have analysed
risks and management of postterm birth also include preg-
nancies from 41+0 GW (late term). Globally, the prevalence
of postterm birth is about 5–10 % [2] but the rate varies
considerably between and within countries. Factors that in-
fluence the prevalence are characteristics of the population
e.g. maternal age and number of primiparous women in the
population, the rate of preterm birth, interventions such as
caesarean section and induction of labour, the prevalence of
routine ultrasound dating of pregnancy and pregnancy sur-
veillance routines [3]. If ultrasound is performed at 40+0 or
41+0 GW, fewer women will reach 42+0 GW as some preg-
nancies will be diagnosed as risk pregnancies leading to in-
duction (e.g. because of oligohydramniosis or small for
gestational age foetuses). The prevalence of postterm birth
(42+0 GW or more) in Sweden was 8.4 % between 1982 and
1991 [4] and 6.9 % in 2013 [5].
The aetiology of postterm birth is largely unknown [2].
Some rare, known causes of postterm birth are foetal an-
encephaly, foetal adrenal hypoplasia or insufficiency and
placental sulphates deficiency. Risk factors for postterm
birth include: primiparity, advanced maternal age, mater-
nal obesity, heredity, previous postterm pregnancy, and
a male foetus [6–10].
Complications in postterm pregnancies
Perinatal mortality (PNM) is defined as the prevalence
of stillbirth (after GW 22+0) and neonatal mortality
within 7 days after birth. The PNM in Sweden between
2004 and 2013 was 0.3‰ in GW 39–41 and 0.7‰ after
42 GW. A Danish national register study (n = 125 043
pregnancies) showed that PNM increased in women
with postterm pregnancies as compared to women with
term pregnancies (adjusted odds ratio (aOR) 1.36; 95 %
CI 1.08–1.72) [8]. A Swedish register study of deliveries
between 1982 and 1991 (n = 914 702 pregnancies) found
significantly higher rates of stillbirth in primiparous women
in GW 41 (1.86‰) and GW 42 (2.26‰) as compared to
GW 40 (1.23‰) [4]. However, in multiparous women the
risk of stillbirth was not significantly different in GW 41
(0.50‰) and 42 (0.86‰) as compared to GW 40 (0.53‰).
These figures were calculated based on the number of
women delivered in each GW. A recalculation with the
number of non-delivered women in each GW (foetuses at
risk) as denominator, showed significantly higher inci-
dences of stillbirth in GW 41 and 42, as compared to GW
40, in primiparous women (0.62, 1.26 and 2.27‰, respect-
ively), as well as in multiparous women (0.73, 1.00 and
1.51‰, respectively). Risk factors for stillbirth in postterm
pregnancies are maternal age and obesity [11].
The risk of perinatal complications such as meconium
aspiration syndrome (MAS), umbilical cord complications,
asphyxia, pneumonia, sepsis, convulsions, shoulder dys-
tocia, traumatic injuries and peripheral nerve damage is
higher in postterm deliveries than in deliveries at term
(aOR 1.1–2.0) [8]. A case-control study from Australia
showed a higher risk of neonatal encephalopathy in chil-
dren born postterm, (GW 41: aOR 3.3 and GW 42: aOR
13.2 versus GW 39) [12]. A Swedish study (n = 354 chil-
dren) found an increased risk for developmental delay at
the age of 4–4.5 years in children born postterm compared
with children born at term [13]. Recently, also increased
rates of obesity and early markers of the metabolic syn-
drome were found in children born postterm [14, 15]. This
may not be a result of prolonged pregnancy per se but ra-
ther associated with foetal and/or parental genetic factors
that also are associated with delayed parturition.
Maternal complications increase from GW 40. The risk
of puerperal infections, postpartum bleeding, disproportion,
labour dystocia, emergency caesarean sections, and cervical
lacerations was higher for postterm than for term pregnan-
cies in a Danish register study (n = 125 043 pregnancies)
(aOR 1.2–1.6) [8].
Postterm pregnancy: induction of labour or
expectant management
Randomised controlled studies (RCTs)
With the increased risks that accompany a postterm
pregnancy, the obvious solution would be to suggest
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induction of labour before the pregnancy becomes post-
term. Several RCTs have compared induction with
awaiting spontaneous onset of labour, with or without
foetal surveillance, but most of the studies are small and
of low methodological quality. The largest study so far is
a multicentre RCT from Canada (n = 3407). The women
were randomised at 41 GW to induction or to expectant
management with monitoring until the start of spontan-
eous labour [16]. The PNM was similarly low in the two
groups but the induced group had significantly fewer
caesarean sections. The study has been criticised because
the induction methods were different in the groups.
Prostaglandins were not used in the expectant manage-
ment group, and it is speculated that this may have con-
tributed to a higher caesarean section frequency in this
group. In a later Norwegian study (n = 500 women),
women were randomised to induction at 289 days (GW
41+2) or monitoring and induction at 300 days (GW 42
+6) unless spontaneous labour [17]. The primary out-
come (a composite neonatal outcome) was similar in the
two groups. No case of stillbirth occurred, and there was
no difference in the rate of caesarean sections. However,
the study was too small to assess PNM, a problem ac-
companied by all RCTs to date. Several systematic re-
views and meta-analyses of RCTs have been published.
In a Health Technology Assessment (HTA) performed at
Sahlgrenska University Hospital (SU) in Gothenburg, 13
RCTs were included (n = 6617 women) [18]. The review
showed no difference in PNM but found significantly
fewer cases of MAS and a lower caesarean section rate
in the induction group as compared to the expectant
management group [18]. An updated HTA meta-analysis
of 17 RCTs (n = 7223 women) was done in 2012, with a
more liberal inclusion of studies (a study from 1969, ab-
stracts and articles in Spanish were added) [19]. It
showed a lower PNM in the induction group, fewer
cases of MAS, and no difference in caesarean section
rate. However, a large number of women need to be in-
duced to prevent one case of perinatal death (NNT =
469). A methodological problem in individual studies
and systematic reviews is that important outcomes such
as PNM and hypoxic ischaemic encephalopathy (HIE)
occur at a very low frequency [20–22]. Thus, very large
studies are needed to address these important outcomes.
Observational studies
A recent register study was based on Medical Birth
Registry (MBR) data on all pregnancies more than 41+2
weeks in Sweden between 2000 and 2007 (n = 119 198
pregnancies) [23]. The management of postterm preg-
nancy in the Stockholm region was changed in 2005
from induction of labour at GW 43+0 to induction at no
later than GW 42+0. Decreases in the rates of PNM (by
48 %), MAS (by 51 %) and low Apgar scores (by 31 %)
were observed. Sweden was divided into three regions
based on the rate of deliveries at more than 42+2 weeks.
It was shown that foetal surveillance differs and that re-
gions with a high rate of deliveries at >GW 42+2 had a
higher rate of neonates with MAS and low Apgar scores.
A recent population-based retrospective cohort study
from Scotland (n = 1 271 549 pregnancies) showed that
induction of labour for non-medical reasons at GW 37,
38, 39, 40 and 41 were associated with reduced PNM,
without an increased risk of caesarean section. However,
more children were admitted to the neonatal ward in
the induced group [24]. An older observational study
[25] compared a group of uncomplicated pregnancies
between 1997 and 1999 (n = 2176) with a group of un-
complicated pregnancies between 1999 and 2002 (n =
3716). Management was changed in 1999 from induc-
tion of labour at GW 42+0 to induction at GW 41+0.
There was no difference in neonatal outcome including
stillbirth between the two time periods, but there were
more prolonged labours and caesarean sections due to
failed inductions between 1999 and 2002.
Risks of labour induction
The RCTs referred to above [16, 17] and the systematic
reviews show that induction compared with expectant
policy in GW 41+0 or later did not increase the frequency
of caesarean sections or instrumental vaginal deliveries.
Earlier observational studies, comparing induction with
spontaneous start of labour at the same gestational age,
showed higher rates of caesarean section after induction,
particularly in women with an unripe cervix [26–28]. A
retrospective cohort study attempted to mimic the clinical
situation by comparing women with induction in a spe-
cific GW (GW 38, 39, 40, 41) with women being undeliv-
ered in the same GW, who were either subsequently
induced or went into spontaneous labour [29]. As with
earlier studies, a higher frequency of caesarean sections
was found after induction, which was statistically signifi-
cant for GW 38, 39 and 40. At GW 41+0 there was no dif-
ference. A recently published meta-analysis of 31 RCTs
(19 studies addressing induction for postterm birth and 12
inductions for other indications) found that induction led
to a lower risk of caesarean section (OR 0.83; 95 % CI
0.76–0.92) [30]. Similar findings are reported in another
recent meta-analysis of 157 RCTs [29, 31].
A register study with data from the Norwegian MBR
between1996 and 1998 (n = 176 591 pregnancies) and
the Norwegian Cerebral Palsy Register (n = 373 children)
found an independent association between induction of
labour at term and bilateral cerebral palsy (CP) (OR 3.7,
95 % CI 1.8–7.5) after adjustment for maternal disease,
gestational age, birth weight, prelabour rupture of the
membranes [32]. However, the authors concluded that
they were only able to speculate on possible mechanisms
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leading to CP after labor induction due to lack of de-
tailed data. Recently, an association between autism
spectrum disorders and induced or augmented child-
birth has been shown [33]. Some evidence suggests an
oxytocin receptor deficiency in autism and the authors
hypothesized that an oxytocin infusion may alter the
oxytocin balance in the newborn.
There is no consensus as to the optimal time of labour
induction or the optimal way of antenatal surveillance.
Recently, guidelines from the Danish Society of Obstetrics
and Gynaecology (DSOG 2011) and the Norwegian Dir-
ectorate of Health (2012) have been published. According
to DSOG, all pregnant women should be delivered before
GW 42+0. A clinical examination is recommended in GW
41+0 including cardiotocography (CTG) and ultrasound.
Induction will be planned for at GW 41+2–41+5, depend-
ing on local tradition. In Norway, a check is also recom-
mended in GW 41+0–41+2 with a clinical examination,
ultrasound, CTG and amniotomy if possible. Induction
should be started no later than GW 42+0. Induction in
GW 41 is recommended for women who are older
(>38 years) or obese, who have gestational diabetes or are
suspected to have a foetus being small for gestational age
(SGA). The American College of Obstetricians and
Gynaecologists (ACOG) recommends starting monitoring
between GW 41+0 and 42+0 with CTG and measurement
of the amniotic fluid index (AFI) twice a week. In Great
Britain, The Royal College of Obstetricians and Gynaecol-
ogists (RCOG) recommend induction between GW 41+0
and 42+0. The Society of Obstetricians and Gynaecologists
of Canada (SCOG) recommends antenatal examination in
GW 41–42, with local guidelines for further action.
Health economic considerations
The Canadian Multicentre Postterm pregnancy trial
from 1995 indicated that induction of labour was associ-
ated with a lower cost as compared with expectant man-
agement of postterm pregnancy [34]. However, as the
study was performed more than 20 years ago the data
may not be applicable today. Induction of labor at 41
GW versus expectant management with antenatal test-
ing in nulliparous women resulted in improved obstetric
outcomes and was cost-effective when analysed with a
decision-analytic model [35]. The incremental cost was
$10,945 per quality-adjusted life year (QUALY) gained
(the range of cost-effectiveness thresholds is commonly
set at $ 50,000–100,000 per QUALY in the USA). Be-
sides the analyses being based on a theoretical cohort,
the authors stated some limitations in the cost-effective
analysis. Much of the data utilized was more than
10 years old and health care costs have rapidly increased.
In addition, they conducted sensitivity analysis over wide
ranges of cost inputs and concluded that better cost data
in this area would facilitate more accurate estimates of
the cost-effectiveness of induction of labour [35].
Women’s experiences
A Swedish study (n = 1111 women) found that induction
of labour irrespective of cause for induction was associ-
ated with a more negative experience of childbirth [36].
This finding is inconsistent with a cross-sectional study
(n = 252 women) from Nigeria, which showed that 71 %
of the women expressed satisfaction with the induction
process [37]. Only one RCT has assessed the woman’s
experiences of induction or expectant policy for post-
term pregnancy (n = 508 women) [38]. At the time of
randomisation, 74 % would have preferred induction if
they had been able to choose. The majority of women
(84 %) who were induced had a positive childbirth ex-
perience. Despite that induction lead to more intensive
labour, 74 % preferred being induced compared with
awaiting spontaneous on-set of labour (p = 0.001).
Aim
The aim with this study is to evaluate if a policy of in-
duction of labour at 41 GW (early induction) is superior,
in terms of neonatal and maternal outcomes, as com-
pared to expectant management and induction at 42+0
(late induction) in healthy women with a low risk single-
ton pregnancy.
Methods/Design
This multicentre registry based randomised controlled trial
named SWEPIS (SWEdish Post-term Induction Study), will
be performed at 4 university clinics and 1 county hospital
in Sweden from 01-09-2015 to 31-08-2018. The centres
comprise more than 65 000 deliveries per year. Eligible par-
ticipants are healthy women ≥18 years old, who are able to
understand oral and written information, with a normal live
singleton pregnancy in cephalic presentation at 41+0 GW,
estimated with a first or second trimester ultrasound.
Women will be excluded if they have had a previous caesar-
ean section or other uterine surgery, pregestational and in-
sulin dependent gestational diabetes, hypertensive disorders
in pregnancy including preeclampsia, multiple pregnancy,
foetus in breech or transverse position, oligohydramniosis
(amniotic fluid index <50 mm or deepest vertical pocket
<20 mm), small for gestational age (<−22 % according to a
Swedish reference [39], foetal malformations and contrain-
dications to vaginal delivery such as placenta previa.
The Regional Ethics Board in Gothenburg approved
the study in May 2014 (Dnr: 285–14).
General information of the study will be available at
each antenatal care unit where women who most likely
chose to give birth at any of the including hospitals will
attend. All pregnant women are given oral and written
information about the study at around GW 40 at the
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antenatal care units. All potentially eligible women will be
consecutively contacted for further information. Women
who are interested in participating in the study are booked
for a visit at the antenatal clinic at the respective hospital
at GW 41+0–41+1. Further information is given and writ-
ten informed consent is obtained. Thereafter, an ultra-
sound examination is performed. Women with a foetus
with an estimated foetal weight <22 % according to the
Swedish gestational and gender adjusted reference curve
and/or AFI <50 mm or DVP <20 mm will not be rando-
mised but will be followed-up according to clinical rou-
tine. Consenting eligible women will be enrolled and
randomised. Eligible women who do not want to partici-
pate in the study will be asked to fill in a web based or
postal written consent for collection of information on
demographic background variables, previous postterm
pregnancy and obstetric and neonatal outcomes (this is to
make it possible to check for selection bias).
Randomisation
Figure 1 shows randomisation and progress through the
trial. The doctor or midwife who performs the ultra-
sound will enrol eligible women. Randomisation will be
completed at the antenatal clinic at GW 41+0 to 41+1.
Block randomisation with a fix block size (unknown to
the investigator) will be done online, 1:1, using the Preg-
nancy Register with a module specifically developed for
the study by MedSciNet AB, Stockholm, Sweden. Strati-
fication will be performed for centre and parity (primi-
parity and multiparity).
Labour induction
Women in the intervention group (early induction) will
be induced within 24 h after randomisation. Women in
the control (expectant management/late induction) will
be induced at GW 42+0 (and no later than GW 42+1).
After randomisation, women in the control group are
followed-up at the ordinary antenatal clinic according to
clinical routine for GW 41+–42+0.
Methods of labour induction (early at GW 41+0–41+2 or
late at GW 42+0–42+1)
Before labour induction the following examinations are
performed: blood pressure, urine analysis, abdominal
and cervical examination and CTG. If there are no con-
traindications for induction of labour, induction will be
performed according to the following:
1. if the foetal head is well engaged and the cervix is
ripe (Bishop score ≥6 for primiparous and ≥5 for
Fig. 1 Flow-shart of the study
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multiparous) amniotomy is performed. Oxytocin
infusion will be started after 2 h if no or not regular
contractions.
2. if the cervix is unripe (Bishop score <6) or the fetal
head is not engaged any of the following methods
are used (according to the routine at the clinic):
a. mechanical dilation using a Foley like catheter
(BARD or Cook)
b. misoprostol (Cytotec®) orally
c. misoprostol (Misodel®) controlled-released vaginal
insert
d. prostaglandin E2 (Minprostin®) gel vaginally
e. prostaglandin E2 (Propess®) vaginal insert
Mechanical dilation may be followed by prostaglandins
and vice versa. If the woman is not in active labour or
cervix is still unripe after 48 h, the clinician together with
the woman will decide whether to perform a caesarean
section or to continue expectant management until GW
42+0. All inductions will be performed with the patient
staying at the hospital until delivery. The clinic’s protocol
and guidelines for induction and surveillance during in-
duction will be followed. During the active phase of labour
fetal surveillance with continuous CTG with or without
ST segment analysis (STAN) in combination with foetal
scalp blood sampling is recommended.
Outcome measures
Primary outcome measure
A composite of stillbirth, neonatal mortality and neonatal
morbidity. Stillbirth is defined as intrauterine foetal death
of a foetus that was alive at randomisation. Neonatal mor-
tality is defined as live births with death day 0–27. Neo-
natal morbidity is defined as at least one of the following
variables: Apgar score <7 at 5 min, metabolic acidosis de-
fined as pH <7.05 and base deficit >12 mmol/l in umbilical
artery or pH <7.00 in umbilical artery, HIE I-III, intracra-
nial haemorrhage, neonatal convulsions, meconium aspir-
ation syndrome (MAS), mechanical ventilation, obstetric
brachial plexus injury.
Secondary outcome measures- neonates
Admittance to neonatal intensive care unit, birth weight,
macrosomia (>4.5 kg), Apgar score <4 at 5 min, thera-
peutic hypothermia, neonatal jaundice, pneumonia, sep-
sis, costs.
Secondary outcome measures-mothers
Use of epidural analgesia, caesarean section, assisted vagi-
nal delivery, duration of labour, episiotomy, perineal lacer-
ations III-IV, shoulder dystocia, postpartum hemorrhage
(>1000 ml), chorioamnionitis, wound infection, urinary
tract infection, endometritis, sepsis, costs.
Data on women’s attitudes, experiences and health-
related quality of life will be collected, only in the Region
Vastra Götaland subpopulation, by questionnaires (web
based or postal).
After randomisation Personality (Big Five), Depression/
anxiety (HADS), Health related quality of life (Euro-Qol –
VAS & Euro-Qol-5D, Self-efficacy (The General Self-
Efficacy Scale (GES) [40–44].
Health-related quality of life (Euro-Qol –VAS & Euro-
Qol-5D, the General Self-Efficacy Scale (GES),
Three months after delivery Depression/anxiety (Hos-
pital anxiety and depression scale, HADS) [44], The
Childbirth Experience Questionnaire (CEQ) [41]. The
instruments will be eligible in English, Spanish, Arabic,
Bosnian, Croatian, Serbian, Farsi and Somali language.
For centres with the same medical record system
e.g.Siemens Obstetrix (Siemens Medical solutions) we
will register data on satisfaction with delivery (Visual
analog scale 0–10) [45].
Data collection
Data on background variables, obstetric and neonatal
outcomes will be obtained from the Swedish Pregnancy
Register and Swedish Neonatal Quality Register (SNQ)
after delivery. The Pregnancy Registry is a certified na-
tional quality registry initiated by the Swedish Health
care that collect and process information all the way
from early pregnancy to a few months after birth. SNQ
is a certified national quality registry initiated by the
Swedish Health care that collect and process informa-
tion about the neonate (www.snq.se).
Statistical analysis
We anticipate that induction of labour at GW 41 as
compared to induction at GW 42 will reduce the pri-
mary outcome by one third from 2.74 to 1.84 % (level of
significance 0.05, power 80 %, dropout rate 10 %). The
primary composite outcome of 2.74 % is based on the
following rates of perinatal mortality and neonatal mor-
bidity in GW 41+3 from Region Skane between 2000 and
2010: HIE 0.22 %, MAS 0.36 %, obstetric brachial plexus
injury 0.05 %, Apgar score <7 at 5 min 1.58 %, stillbirth
and neonatal mortality 0.53 %. We need a sample size of
10 038 women to be randomised, 5 019 to induction of
labour at GW 41+0 and 5 019 to expectant management.
Since primary outcome is a serious and rare event, we
consider that a 33 % reduction is clinically relevant. In
2013, Region of Vastra Gotaland, Region Skane,
Stockholm and Uppsala had 18 261, 14 719, 28 335 and
3 787 deliveries, respectively, altogether 65 102 deliver-
ies. During a 3 year period we calculate with 195 306 de-
liveries. Given a rate of 18 % of women being
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undelivered at 41+0 GW, this will give us 34 755 women
during 3 years. We estimate that around 33 % (11 469)
of these women can be included.
The primary statistical analysis will be the comparison
of primary composite outcome (stillbirth, neonatal mor-
tality and morbidity) between the two randomised
groups with two-sided Fisher’s exact test on the
intention to treat (ITT) [46] populations at significance
level 0.05. Adjustments for baseline variables if necessary
and interaction analyses will be performed with multi-
variable logistic regression analyses. For variables with
interactions p <0.10 with primary efficacy variable, sub-
group analyses will be performed. Women with spontan-
eous labour or prelabour rupture of the membranes
(PROM) after randomisation but before planned induc-
tion will be included in the statistical analysis according
to ITT. Women with pregnancy complications after ran-
domisation indicating any need of intervention are in-
cluded in the statistical analysis according to ITT.
Foetuses/newborns with lethal birth defects will be ex-
cluded in the analysis of stillbirth, neonatal mortality
and morbidity. The median, 95 % CI, quartiles, means
and SD are calculated when appropriate. The Mann–
Whitney U test is used to compare differences between
the two groups concerning continuous variables, Fisher’s
exact test for dichotomous variables, Mantel-Haenszel
Chi-square test for ordered categorical variables and
Chi-square test for unordered categorical variables.
The statistician will be blinded to group and interven-
tion. Otherwise blinding is not possible for practical
reasons.
Cost-effectiveness analyses
Cost-effectiveness analyses will be performed comparing
induction at GW 41+0 with induction at GW 42+0. The
primary measures of effectiveness will be a composite of
stillbirth, neonatal mortality and neonatal morbidity (i.e.
primary outcome) [47]. A broad range of sensitivity ana-
lyses will be performed, which includes calculating CIs
of the cost-effectiveness measures, using bootstrapping
[47]. In order to extrapolate the outcomes observed in
this study to a longer time span we will utilize a simulation
model. The model will be constructed and parameterized
using estimates of relevant parameters obtained within the
project. Moreover, associations between neonatal outcomes
and health outcomes later in life that was not studied in
this project will be collected from the epidemiology litera-
ture. Initially, two modelling structures will be considered:
a Markov structure and a discrete event structure [48]. The
typical Markov model uses a cohort and state-transition
technique, while the discrete event structure means that
simulations are event-based and performed at the individ-
ual level. The choice between these two main alternatives
will be performed according to the guidelines provided in
Brennan et al. [48].
Serious adverse events
The following serious adverse events (SAE) will be iden-
tified: stillbirth, neonatal death, severe neonatal morbid-
ity, defined as intraventricular haemorrhage, asphyxia or
MAS with admission to NICU, maternal death, severe
maternal morbidity defined as admission to intensive
care unit and events related to induction of labour e.g.
uterine rupture. All SAEs are reported to the main in-
vestigators, who will report to the Data and Safety Moni-
toring Board (DSMB).
Data safety
The steering committee’ is responsible for the study de-
sign, the co-ordination between centres, the progress of
the study, and for the results being statistically analysed
and summarised for publication. The steering committee
are also principal investigators, i.e. they are responsible
for the project at their own centre for example adher-
ence to the study protocol, recruitment and any practical
problem that may arise within the frame of the project.
The DSMB consist of experts (one statistician, a senior
obstetrician and a midwife) who will supervise the study.
The DSMB will secure the project management through
periodical reviews and will make the recommendations
concerning the continuation, modification or termin-
ation of the trial.
Trial status
Besides the literature search resulting in the systematic
review and meta-analysis and the HTA reports [18, 19]
there are no clinical results. Overall recruitment start
date: 01/09/2015 and overall trial end date: 31/12/2018.
Discussion
The planned study is the first RCT utilising the national
Pregnancy Register (developed by co-applicant OS) for
collecting data on maternal characteristics, pregnancy,
delivery and postnatal care and SNQ for data on neo-
natal outcome. Randomisation will be performed using a
computerised module linked to the Pregnancy Register.
Such a design has recently been applied successfully in
cardiovascular research [49, 50] and has several import-
ant advantages including costs, ease of recruitment and
facilitating the translation of the study results to clinical
practice.
Our primary and secondary outcome measures are in
the interest of the woman, the expectant partner and the
child. There are no high quality studies with adequate
sample size investigating if early induction is superior to
standard care (expectant management/late induction) in
terms of maternal and neonatal outcomes. The optimal
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timing of offering induction of labour to women at late
term or postterm therefore needs further investigation.
Women’s experiences and opinions about the choices
have not been adequately evaluated. In this study, we
also aim to evaluate women’s attitudes and experiences
with questionnaires. In the early induction group we will
have a higher proportion of induction of labour, with
possible negative delivery experiences. In the late induc-
tion group, the proportion of induction will be lower,
but the experience of another week of waiting “post due
date” is not evaluated. Further, the foetal growth con-
tinues between 41 and 42 GW, leading to an expected
higher infant birth weight and more “macrosomic in-
fants” (>4.5 kg) in the late compared to the early induc-
tion group. Giving birth to macrosomic infants is
associated with more complications, leading to a pos-
sible more negative experience in the late induction
group. The outcome “women’s experiences and opin-
ions” of each intervention (early or late induction) is
thus complex and therefore an important outcome of
our study. One of the advantages of the register-based
design is that the primary and secondary outcomes will
be collected continuously through national quality and
health registers. These data can be used for implementa-
tion after the study has been finalized. The conse-
quences of a new clinical management can be evaluated
(reduction in e.g. perinatal mortality, HIE, caesarean sec-
tion etc.) using national data from the Pregnancy Regis-
ter and SNQ. The study results will fill several gaps in
health care knowledge and contribute to establish good
evidence-based routines regarding management of post-
term pregnancy. Support for if an early intervention in
the natural course of pregnancy is superior for the
health of children and mothers is important, to justify
an intervention (labour induction) in 15–20 % of all
women whose pregnancy has lasted ≥41+0 GW in the fu-
ture. Sweden is suited to run a high quality RCT: public
health care system, almost 100 % of pregnant women at-
tend antenatal care, nearly everybody gives birth at a de-
livery hospital and there is usually (except the
Stockholm region) only one hospital with a delivery
ward for a certain geographic region (reduces selection
bias), low rates of maternal and perinatal mortality, com-
parably low caesarean section rates and opposed to
many other countries we have not yet started to induce
earlier so we still have the possibility to run this RCT.
Also, this project is the first study supported by the re-
cently started Swedish National Network on Clinical
Studies in obstetrics and gynaecology (SNAKS). The net-
work comprises one member from each university re-
gion in Sweden and is supported by the Swedish Society
of Obstetrics and Gynaecology (SFOG). If the interven-
tion, early induction, is shown to be superior to expect-
ant management/late induction, new local, regional and
national guidelines may therefore be developed within a
short time frame (approximately 3 years).
Project organization and co-workers
The following five centres will participate in the study:
the Departments of Obstetrics and Gynecology at South
Alvsborg County Hospital (SAS), Sahlgrenska University
Hospital, Skane University Hospital (SUS), Karolinska
Hospital Solna/Huddinge, Stockholm, Uppsala University
Hospital. Our aim is to include most of the centres in
Sweden through SNAKS. The project will be led by a
steering committee which preliminarily has the following
members: Associate professor Ulla-Britt Wennerholm,
Professor Henrik Hagberg, Professor Christina Bergh, As-
sociate professor Andreas Herbst, PhD Maria Bullarbo,
PhD Helen Elden, PhD Verena Sengpiel, PhD Sissel Salt-
vedt, Associate professor Olof Stephansson, Associate
professor Anna-Karin Wikström and Associate professor
Lars Ladfors. The steering committee is responsible for
the study design, the co-ordination between centres, the
progress of the study, and for the results being analysed
and summarised for publication. The steering committee
are also principal investigators, i.e. they are responsible for
the project at their own centre for example adherence to
the study protocol, recruitment and any practical problem
that may arise within the frame of the project.
There will be further coordinating clinical investigators
at each site. One midwife will be responsible for the
study implementation at each site. At SU this will be
Anna Wessberg, midwife and registered PhD student.
Professor in Health Economics Kristian Bolin is respon-
sible for the health economic analysis and Nils Gunnar
Pehrsson is responsible for the statistical analysis.
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